Inhibition of connexin GJCs and HCs, such as Cx26 and Cx43, has been suggested to be a promising strategy in treatment of KID syndrome (Cx26) [17], arrhythmias (Cx43) [18], and in acceleration of wound healing (Cx43) [19]. The gene discussed is GJB2; the disease is KID syndrome.